EP
SMTI icon

Essential Partners’s Sanara MedTech SMTI Stock Holding History

Essential Partners’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.69K Sell
114
-104
-48% -$2.15K ﹤0.01% 1848
2026
Q1 		$3.75K Buy
218
+209
+2,322% +$4.3K ﹤0.01% 1718
2025
Q4 		$210 Buy
9
+8
+800% +$207 ﹤0.01% 2424
2025
Q3 		$32 Sell
1
-1
-50% -$30 ﹤0.01% 2608
2025
Q2 		$57 Buy
+2
New +$60 ﹤0.01% 2138

Other funds holding SMTI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 8.37% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Essential Partners's SMTI Position: Q2 2026 in Review

Essential Partners reduced its Sanara MedTech (SMTI) stake by 48% in Q2 2026, selling an estimated $2.15K and leaving 114 shares worth $2.69K. The position accounts for ﹤0.01% of the portfolio, ranked #1848.

Essential Partners first reported a position in SMTI in Q2 2025 and has held it in 5 quarters since. The position peaked at $3.75K in Q1 2026. 74 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

  • Essential Partners held 114 shares of Sanara MedTech worth $2.69K as of Q2 2026.
  • Essential Partners sold 104 Sanara MedTech shares in Q2 2026, an estimated $2.15K.
  • Sanara MedTech made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #1848 holding.
  • Essential Partners first reported a position in Sanara MedTech in Q2 2025 and has held it in 5 quarters since.
  • Essential Partners's Sanara MedTech position peaked at $3.75K in Q1 2026.
  • 74 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.